-
Boyfriend's spat? Take a kiss to change the pig's head, kiss a bit itchy red ness, and then... There's no more.
Time of Update: 2020-07-14
A movie-loving friend will find an interesting phenomenon allergic to the eggs, bananas, cream, peanuts No precursors, sudden seizures! for screenwriters "allergy" material is really
-
Heterogeneous Cell Therapy FCR001 For The Treatment of Severe Sclerotic Disease: IND Approved by FDA
Time of Update: 2020-07-14
Scleropathy, also known as systemic sclerosis (SSc), is divided into localized types of skin-only symptoms that do not invade the visceral system or systemic sclerosis that will invade the visceral
-
World Allergy Day: What to do when i'm being targeted by allergies?
Time of Update: 2020-07-14
July 8 is the 16th World Allergy Diseases Day hope to fight the new crown pneumonia epidemic at the same time do not ignore the "hidden killing machine" allergy disease with the progress
-
Lancet Rheumato: Vulnerable to autoimmune rheumatoid diseases for new crown pneumonia
Time of Update: 2020-07-14
Recently, researchers examined the COVID-1 9 susceptibility of auto immuno rheumatism disease in patients with the COVID-19 pandemic researchers conducted a multi-center retrospective study of
-
Cell: High pressure, poor ability! Cell reveals brown fat cell stress mechanism
Time of Update: 2020-07-14
In stressful environments, the body secretes hormones such as cortisol and adrenal, which should have weakened the inflammatory response, why under heavy pressure, inflammation is actually aggravated?
-
New medicine for baldness! The U.S. FDA awarded the new anticosis JAK1/2 inhibitor CTP-543 breakthrough drug qualification, treatment of severe baldness significant effect!
Time of Update: 2020-07-14
, July 09, 2020 /PRNewswire/ -- Biovalley BIOON/Concert Pharma is a clinical biopharmaceutical company that develops small molecule drugs for the treatment of central nervous system diseases, gene
-
Spots or medicine available! CTP-543 Obtains FDA Breakthrough Therapy Recognition
Time of Update: 2020-07-14
The Pharmaceutical Company concert recently announced that the U.S Food and Drug Administration Administration ( FDA ) has awarded oral Janus kinase inhibitor CTP-543 breakthrough therapy for the
-
Middle-aged women, fatigue with anemia for more than a month, please diagnose!
Time of Update: 2020-07-14
Department of Oncology department "Basic Information" patients, female, 51-year-old "Main complaint" fatigue with anemia for one month "Image" the of diagnosis? discussion
-
Semin Arthritis Rheu: Efficacy and safety of Kanano supra-resistant treatment of Schnitzler syndrome
Time of Update: 2020-07-13
Schnitzler syndrome is a rare auto-inflammatory disease characterized by chronic urticaria and monoclonal propylene globulin disease, accompanied by intermittent fever, bone pain, joint pain, or art
-
Semin Arthritis Rheu: Does type 2 diabetes increase the risk of musculoskeletal pain?
Time of Update: 2020-07-13
The study explored the correlation between cross-sections and whether type 2 diabetes increased the risk of musculoskeletal pain after adjusting for important complications the study used data f
-
Gastroenterology: Upadacinib's treatment of moderate-to-severe Crohn's disease phase II clinical success
Time of Update: 2020-07-13
Recently, researchers evaluated the efficacy and safety of Upadacitinib, an oral selective Janus kinase 1 inhibitor, for Crohn's disease (CD) the study was a double-blind, Phase 2 trial in which
-
Nat commun: Living conditions determine our susceptibility to disease, junk food can "detonate" negative effects
Time of Update: 2020-07-13
On June 16, Beijing's emergency response level was raised from three to two Therefore, from kindergarten to college students, and many active employees have to live a home at home During this period
-
Clin Rheumatol: Prognostic factors for early recurrence of gout in patients who started uric acid reduction treatment during acute gout attacks
Time of Update: 2020-07-13
Reducing serum urate levels below the crystal formation threshold with urate-reducing therapy (ULT) is associated with a reduced risk of recurrence of gout attacks However, gout patients with ULT of
-
J Rheumatol: Airway and pulmonary substance lesions with primary dry syndrome
Time of Update: 2020-07-13
The study was designed to assess the progression of lung function and chronic obstructive pulmonary disease (COPD) in patients with primary dry syndrome (pSS) over time, as well as the association b
-
Ann Rheum Dis: Long-term efficacy and safety of caratmonosine in patients with familial Mediterranean fever resistant to autumn daffodils
Time of Update: 2020-07-13
The study was designed to assess the long-term efficacy and safety of cluster study Phase 4 (41 weeks to 113 weeks) in the use of kanamonotox to treat familial Mediterranean fever patients (crFMF) w
-
Sci Rep: Serum ferritin levels, iron metabolism and osteoporosis of rheumatoid arthritis
Time of Update: 2020-07-13
Ferrinin is the main regulator of iron metabolism and steady state in the body, regulated by inflammation Recent studies have shown that ferritin and iron metabolism are associated with osteoporosi
-
Semin Arthritis Rheu: Clinical Manifestations of Aeritis
Time of Update: 2020-07-13
Aorticitis (TAK) is a clinical heterogeneous disease THE TYPE OF CLINICAL MANIFESTATIONS OF TAK IN DIAGNOSIS HAS NOT BEEN WELL DESCRIBED AND HAS BEEN REPORTED TO HAVE SYSTEMIC SYMPTOMS EVOLVING IN
-
Arthritis Rheumatol: Does smoking and socioeconomic factors affect imaging results for mid-axis spinal arthritis?
Time of Update: 2020-07-13
The study looked at the relationship between smoking and imaging outcomes in patients with axSpA over a five-year time and assessed whether socioeconomic (SE) factors influenced these relationships
-
Semin Arthritis Rheu: Characteristics of COVID-19 infection in patients with influenzae treatment with immunosuppressants
Time of Update: 2020-07-13
The purpose of this study was to analyze the clinical characteristics and prognosis of infection in patients treated with immuno inhibitors coVID-19 studied a range of RD patients who treated
-
J Rheumatol: Hospital burden of granulated polyvascular disease
Time of Update: 2020-07-13
Heart vascular disease is a serious complication of granulated polyvastovassis (GPA) The study analyzed the trend of coronary artery disease (CAD) and its two serious manifestations, acute myocar
